GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CDLX · Dec 31, 2024

Cardlytics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001666071-25-000034General Corporate
Debt relative to revenue50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

85.51% · OPTIONAL · VALID

Capex intensity35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.61% · OPTIONAL · VALID

Operating cash generation60thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-3.45% · OPTIONAL · VALID

Revenue growth20thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

-10.44% · CORE · VALID

Operating margin15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

-76.48% · CORE · VALID

R&D intensity60thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

19.41% · OPTIONAL · VALID

SBC intensity40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

15.79% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History29 statesSelf-history eligible
Sep 30, 20214/4 normalizedLevel 3Dec 31, 20217/7 normalizedLevel 3Dec 31, 20216/6 normalizedAmended as filedMar 31, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20227/7 normalizedLevel 3Mar 31, 20237/7 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20237/7 normalizedLevel 3Mar 31, 20247/7 normalizedLevel 3Jun 30, 20247/7 normalizedLevel 3Sep 30, 20247/7 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
348.94%
Current
85.51%
Delta
-263.43%
Capex Intensity Decreased
Previous
0.83%
Current
0.61%
Delta
-0.22%
Cash Generation Decreased
Previous
2.27%
Current
-3.45%
Delta
-5.72%
Growth Increased
Previous
-16.36%
Current
-10.44%
Delta
5.92%
Profitability Increased
Previous
-243.08%
Current
-76.48%
Delta
166.60%
R And D Intensity Decreased
Previous
21.59%
Current
19.41%
Delta
-2.18%
Sbc Intensity Increased
Previous
13.20%
Current
15.79%
Delta
2.59%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · CDLX historical state 2025-03-31 →Has State · Cardlytics, Inc. →Transitioned To · CDLX Fundamental State →Transitioned To · CDLX BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · CDLX CAPEX_INTENSITY_DECREASED →Transitioned To · CDLX CASH_GENERATION_DECREASED →Transitioned To · CDLX GROWTH_INCREASED →Transitioned To · CDLX PROFITABILITY_INCREASED →Transitioned To · CDLX R_AND_D_INTENSITY_DECREASED →Transitioned To · CDLX SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.